Cytomegalovirus Exposure and Cardiovascular Disease in Kidney Transplant Recipients

By Courivaud Ccile   Bamoulid Jamal   Chalopin Jean-Marc   Gaiffe Emilie   Tiberghien Pierre   Saas Philippe   Ducloux Didier  

The Journal of Infectious Diseases, Vol. 207, Iss. 10, 2013-05 ,pp. : 1569-1575

Oxford University Press

Access to resources Recommend Favorite

Current and Emerging Antivirals for the Treatment of Cytomegalovirus (CMV) Retinitis: an Update on Recent Patents

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 7, Iss. 1, 2012-04 ,pp. : 8-18

Bentham Science Publishers

Access to resources Recommend Favorite

CMV prophylaxis: a useful step towards prevention of post-transplant diabetes?

By Smith R.  

Diabetologia, Vol. 47, Iss. 9, 2004-09 ,pp. : 1473-1475

Springer Publishing Company

Access to resources Recommend Favorite

CMV pp65 antigen testing is of limited utility in the diagnosis of concomitant CMV disease in HIV-infected patients in the HAART era

By Skiest D.J.   Crosby C.  

Journal of Clinical Virology, Vol. 28, Iss. 2, 2003-10 ,pp. : 203-213

Elsevier

Access to resources Recommend Favorite

Efficacy of a strategy for discontinuing pre-emptive ganciclovir therapy after a negative cytomegalovirus antigenaemia test result in seropositive kidney transplant recipients

By Park So-Youn   Kim Young Hoon   Han Duck Jong   Park Su-Kil   Park Jung Sik   Sung Heungsup   Park Hyun Jung   Kim Sung-Han   Choi Sang-Ho   Kim Yang Soo   Woo Jun Hee   Lee Sang-Oh  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 5, 2013-05 ,pp. : 1209-1211

Oxford University Press

Access to resources Recommend Favorite